October 16, 2020
Loren Walensky, Lytica Scientific Cofounder, recognized by Nature Biotechnology as One of the World's Top 20 Translational Researchers of 2019
February 18, 2020
Lytica Therapeutics Receives CARB-X Award For Up To $16.9 Million To Develop Antimicrobial Peptides To Treat Drug-Resistant Infections
October 7, 2019
Stapled Antimicrobial Peptide Design, as published in the October Issue of Nature Biotechnology
Copyright © 2019-2020 Lytica Therapeutics, Inc - All Rights Reserved.